SURGERY FOR RECURRENT COLORECTAL-CARCINOMA - IS IT WORTHWHILE
- 1 September 1989
- journal article
- research article
- Vol. 71 (5) , 293-298
Abstract
A series of 45 patients undergoing a second operation for recurrent colorectal cancer is reported. The majority developed recurrence within 2 years of their initial surgery. Despite regular follow-up, in only 27% of patients submitted to further surgery was the recurrence detected at routine review, and only three of these were asymptomatic at the time of diagnosis. A potentially curative second procedure was undertaken in 47% of cases, with a 2-year survival of 71% and a 5-year survival of 29%. Of those undergoing palliative surgery, this was worthwhile in 64%, providing palliation for more than 6 months. Mean survival following a palliative procedure was 10 months. Palliation was better, and operative mortality lower, when the bulk of the tumour could be removed. In obstructed patients the outcome following palliative resection was better than for palliative bypass procedures. Following resection of metastases there is the prospect of long-term survival, but it is difficult to predict those patients who will do well.This publication has 39 references indexed in Scilit:
- Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracyDiseases of the Colon & Rectum, 1987
- Major hepatic resection for colorectal liver metastasesBritish Journal of Surgery, 1987
- Follow-up of colorectal cancer resected for cureDiseases of the Colon & Rectum, 1987
- Surgical Treatment of Hepatic Metastases from Colorectal CancerAnnals of Surgery, 1986
- CEA-Directed Second-look Surgery in the Asymptomatic Patient after Primary Resection of Colorectal CarcinomaAnnals of Surgery, 1985
- Failure Patterns Following Curative Resection of Colonic CarcinomaAnnals of Surgery, 1984
- Survival of 727 patients with single carcinomas of the large bowelDiseases of the Colon & Rectum, 1984
- Recurrent cancer of the large bowel.BMJ, 1983
- MONOCLONAL ANTIBODY WHICH AGGLUTINATES ERYTHROCYTES FROM CANCER PATIENTSThe Lancet, 1982
- Pelvic Recurrence after Excision of Rectum for CarcinomaBMJ, 1963